Needham & Company Starts Clearside Biomedical (CLSD) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Cowen Starts Clearside Biomedical (CLSD) at Outperform
June 27, 2016 6:46 AM EDTCowen initiated coverage on Clearside Biomedical (NASDAQ: CLSD) with an Outperform rating.
For an analyst ratings summary and ratings history on Clearside Biomedical click here. For more ratings news on Clearside Biomedical click here.
Shares of Clearside Biomedical closed at $6.80 yesterday.
... MoreWedbush Starts Clearside Biomedical (CLSD) at Outperform, $28 PT
June 27, 2016 6:20 AM EDTWedbush initiates coverage on Clearside Biomedical (NASDAQ: CLSD) with a Outperform rating and a price target of $28.00.
Analyst Liana Moussatos commented, "We believe an investment in CLSD supports a dramatic improvement in injectable drug delivery for multiple eye diseases."
She added, "Clearside is a... More
